Clinical Trial –Biomarker Identification – Bladder Cancer

The Ohio State University Comprehensive Cancer Center is running a study to improve a test for people with bladder cancer. To develop a simple blood and urine test that would be performed before patients start their treatment to predict the risk that their bladder cancer might reoccur. During the study, researchers analyze patients’ blood, urine and cancer tissue. They follow these patients closely during and after their treatment.

The procedure is sample collection.

Study Type : Observational
Estimated Enrollment : 179 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Biomarker Identification for Bladder Cancer Patients
Actual Study Start Date : January 21, 2014
Estimated Primary Completion Date : November 30, 2018
Estimated Study Completion Date : November 30, 2018

For enrollment please visit

Contacts: Ohio State University Comprehensive Cancer Center      1-800-293-5066 [email protected]

Reference Code: NCT02053662

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.